Effect of stilbestrol on the isoenzymes of lactate dehydrogenase in benign and malignant prostatic tissue.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D004054:Diethylstilbestrol / Q000494:pharmacology*; D004967:Estrogens / Q000627:therapeutic use; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D066298:In Vitro Techniques; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000378:metabolism*; D008297:Male; D008777:Methyltestosterone / Q000494:pharmacology; D011467:Prostate / Q000201:enzymology*; D011468:Prostatectomy; D011469:Prostatic Diseases / Q000201:enzymology*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000201:enzymology*; D014750:Vincristine / Q000494:pharmacology
D000970:Antineoplastic Agents; D004967:Estrogens; D007527:Isoenzymes; D003609:Dactinomycin; D014750:Vincristine; D004054:Diethylstilbestrol; D003520:Cyclophosphamide; D007770:L-Lactate Dehydrogenase; D005472:Fluorouracil; D008777:Methyltestosterone; D006854:Hydrocortisone